\
&
Contact us
\
&
Contact us
Starts in 3 weeks from now
LocationBrussels
The European Commission is organizing the CEF Digital Community Conference in collaboration with the European Health and Digital Executive Agency (HaDEA). This event will highlight the progress made in interconnecting national and regional networks through submarine cables and terrestrial backbones, along with future investment perspectives.
The conference will provide a platform to explore key themes including:
Participants from the 5G smart communities and corridors are invited to engage in discussions aimed at shaping tomorrow's connectivity strategies, ultimately enhancing the competitiveness of the European digital sector.
Target audience: researchers, industry professionals, policy makers, investors, with an interest in critical themes of digital connectivity.
For more information on the event, its agenda, and to register, please visit the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
